My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.

    Dore DD, Lapane KL, Trivedi AN, Mor V, Weinstock MA.

    Ann Intern Med. 2009 Jan 6;150(1):9-18.PMID: 19124815 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

    Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

    J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. Epub 2008 Aug 26.PMID: 18728281 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Topical tretinoin therapy and all-cause mortality.

    Weinstock MA, Bingham SF, Lew RA, Hall R, Eilers D, Kirsner R, Naylor M, Kalivas J, Cole G, Marcolivio K, Collins J, Digiovanna JJ, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group.

    Arch Dermatol. 2009 Jan;145(1):18-24.PMID: 19153339 [PubMed - indexed for MEDLINE]Related articles

    4.

    Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

    Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group.

    Cancer. 2009 Jun 1;115(11):2523-30.PMID: 19382202 [PubMed - indexed for MEDLINE]Related articles

    5.

    Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

    Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

    J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.PMID: 14519754 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

    Weinstock MA, Lee KC, Chren MM, Marcolivio K; VATTC Trial Group.

    J Am Acad Dermatol. 2009 Aug;61(2):207-15. Epub 2009 Apr 26.PMID: 19398145 [PubMed - indexed for MEDLINE]Related articles

    7.

    Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

    Geng A, Weinstock MA, Hall R, Eilers D, Naylor M, Kalivas J; VATTC Trial Group.

    Br J Dermatol. 2009 Oct;161(4):918-24. Epub 2009 Jun 11.PMID: 19681859 [PubMed - in process]Related articles

    8.

    A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.

    Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH.

    Arch Dermatol. 2000 Feb;136(2):179-84.PMID: 10677093 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.

    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.

    Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):157-61.PMID: 9488591 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group.

    Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS.

    JAMA. 1992 Jun 24;267(24):3305-10.PMID: 1597912 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

    Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR.

    JAMA. 1996 Dec 25;276(24):1957-63. Erratum in: JAMA 1997 May 21;277(19):1520. PMID: 8971064 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.

    Clouser MC, Roe DJ, Foote JA, Harris RB.

    Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):276-83.PMID: 19226541 [PubMed - indexed for MEDLINE]Related articles

    13.

    Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.

    Rodriguez-Vigil T, Vázquez-López F, Perez-Oliva N.

    J Am Acad Dermatol. 2007 Jan;56(1):91-5.PMID: 17190625 [PubMed - indexed for MEDLINE]Related articles

    14.

    The association between statins and cancer incidence in a veterans population.

    Farwell WR, Scranton RE, Lawler EV, Lew RA, Brophy MT, Fiore LD, Gaziano JM.

    J Natl Cancer Inst. 2008 Jan 16;100(2):134-9. Epub 2008 Jan 8.PMID: 18182618 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

    Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

    Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):949-56.PMID: 9367069 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.

    Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, Stukel TA, Mandel JS.

    Int J Cancer. 2006 Aug 1;119(3):682-6.PMID: 16496410 [PubMed - indexed for MEDLINE]Related articles

    17.

    A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.

    Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, Vigneault E, Vass S, del Vecchio P, Roy J.

    J Natl Cancer Inst. 2005 Apr 6;97(7):481-8.PMID: 15812073 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.

    Tangrea J, Edwards B, Hartman A, Taylor P, Peck G, Salasche S, Menon P, Winton G, Mellette R, Guill M, et al.

    Control Clin Trials. 1990 Dec;11(6):433-50.PMID: 1963135 [PubMed - indexed for MEDLINE]Related articles

    19.

    Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.

    Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney P, Battistutta D, Frost C, Lang C, Russell A.

    Lancet. 1999 Aug 28;354(9180):723-9. Erratum in: Lancet 1999 Sep 18;354(9183):1038. PMID: 10475183 [PubMed - indexed for MEDLINE]Related articles

    20.

    Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

    Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M.

    J Natl Cancer Inst. 2007 Feb 21;99(4):283-90.PMID: 17312305 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity